HCAP Partners Invests in DFW Neuropathy

HCAP Joins Baymark Partners in Investing in Neuropathy Treatment Company SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — HCAP Partners, a California-based private equity firm and nationally recognized impact investor, today announced its investment in DFW Neuropathy, a neuropathy treatment…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks